These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20634652)

  • 41. Medical device epidemiology and surveillance: patient safety is the bottom line.
    Brown SL; Bright RA; Tavris DR
    Expert Rev Med Devices; 2004 Sep; 1(1):1-2. PubMed ID: 16293003
    [No Abstract]   [Full Text] [Related]  

  • 42. Medical devices. Part II. The Medical Device Amendments 10 years after. Interview by William Rados.
    Villforth J
    FDA Consum; 1986 May; 20(4):28-32. PubMed ID: 10311541
    [No Abstract]   [Full Text] [Related]  

  • 43. What is the Medical Device and Lab Product Problem Reporting Program?
    Moore R
    Pharm Times; 1982 Nov; 48(11):53-7. PubMed ID: 10257641
    [No Abstract]   [Full Text] [Related]  

  • 44. The extrapolation of study results in the device approval process.
    Somberg JC
    Am J Cardiol; 2009 May; 103(9):1323-4. PubMed ID: 19406280
    [No Abstract]   [Full Text] [Related]  

  • 45. Federal medical device regulations: what are the implications for respiratory care?
    Gardner RM
    Respir Care; 1988 Apr; 33(4):258-63. PubMed ID: 10315749
    [No Abstract]   [Full Text] [Related]  

  • 46. Food and Drug Administration control of medical devices: an inescapable intrusion and stimulus for adaptation.
    Friedman EA
    ASAIO J; 1998; 44(4):239-40. PubMed ID: 9682946
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving the security and privacy of implantable medical devices.
    Maisel WH; Kohno T
    N Engl J Med; 2010 Apr; 362(13):1164-6. PubMed ID: 20357279
    [No Abstract]   [Full Text] [Related]  

  • 48. Highly publicized medical device failures have made headlines in the lay press.
    Szycher M
    J Biomater Appl; 1994 Oct; 9(2):99-101. PubMed ID: 7782999
    [No Abstract]   [Full Text] [Related]  

  • 49. A US FDA medical device update, Part II.
    Donawa ME
    Med Device Technol; 1996 Sep; 7(7):12-6, 18. PubMed ID: 10163518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From regulation to registration. Safety and performance needs drive industry consensus on voluntary servicing, remarketing controls.
    Hatem MB
    Biomed Instrum Technol; 1999; 33(5):393-8. PubMed ID: 10511908
    [No Abstract]   [Full Text] [Related]  

  • 51. US regulation of combination products.
    Donawa M
    Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The device development pinata.
    Somberg JC
    Am J Ther; 2011 Sep; 18(5):339. PubMed ID: 21912221
    [No Abstract]   [Full Text] [Related]  

  • 53. Medical device specificities: opportunities for a dedicated product development methodology.
    Santos IC; Gazelle GS; Rocha LA; Tavares JM
    Expert Rev Med Devices; 2012 May; 9(3):299-311. PubMed ID: 22702261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Food and Drug Administration should regulate medical devices--not hospitals.
    Belkin NL
    Am J Infect Control; 2003 Dec; 31(8):499-501. PubMed ID: 14647112
    [No Abstract]   [Full Text] [Related]  

  • 56. Watchdog group says "massive lobbying effort" by medical device industry threatens public health.
    Lenzer J
    BMJ; 2012 Feb; 344():e1521. PubMed ID: 22374926
    [No Abstract]   [Full Text] [Related]  

  • 57. Is the device development process adequate.
    Somberg JC
    Am J Ther; 2010; 17(2):123-4. PubMed ID: 20305398
    [No Abstract]   [Full Text] [Related]  

  • 58. FDA user fee and Modernisation Act.
    Donawa M
    Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent legal developments affecting medical device manufacturers.
    Lough MH
    Healthspan; 1993 Sep; 10(8):21-3. PubMed ID: 10129148
    [No Abstract]   [Full Text] [Related]  

  • 60. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.